Brief: Interpace Biosciences Q2 Revenue USD 12.001 Million
Aug 01 (Reuters) - Interpace Biosciences Q2 operating income USD 2.216 million. * Q2 net income USD 2.021 million * Q2 operating expenses USD 5.174 million * Q2 gross profit USD 7.39 million
Aug 01 (Reuters) - Interpace Biosciences Q2 operating income USD 2.216 million. * Q2 net income USD 2.021 million * Q2 operating expenses USD 5.174 million * Q2 gross profit USD 7.39 million